This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Easing the Burden of Treatment-Resistant Depression

Maurizio Fava, MD; J. Craig Nelson, MD; Michael E. Thase, MD; and Madhukar H. Trivedi, MD

Published: February 16, 2009

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Depression is one of the leading causes of disability worldwide and affects 121 million people. Individuals with depression experience significant cognitive, behavioral, and physical impairments related to this disorder. Although depression is a highly treatable illness, the majority of patients with depression do not receive adequate treatment, and few patients who do receive adequate treatment achieve full symptomatic remission.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...